Truqap

ESMO: AstraZeneca stands by Truqap despite surprise breast cancer flop
Fierce Pharma
Fri, 09/13/24 - 11:00 am
AstraZeneca
ESMO
FDA
Truqap
Relay races toward pivotal trial as breast cancer data tee up clash with AstraZeneca's Truqap
Fierce Biotech
Mon, 09/9/24 - 11:01 am
Relay Therapeutics
breast cancer
RLY-2608
AstraZeneca
Truqap
clinical trials
AstraZeneca’s Truqap flops in phase III triple-negative breast cancer trial
BioSpace
Tue, 06/18/24 - 11:46 am
AstraZeneca
Truqap
triple-negative breast cancer
AstraZeneca’s AKT Inhibitor Wins FDA Approval for Combo Breast Cancer Treatment
BioSpace
Sun, 11/19/23 - 09:36 pm
AstraZeneca
Truqap
breast cancer
FDA Approves Truqap Plus Faslodex for Advanced HR-Positive Breast Cancer
Pharm Exec
Fri, 11/17/23 - 10:09 am
AstraZeneca
Truqap
breast cancer
HR-positive